APA (7th ed.) Citation

Lin, L., Nian, Y., Lin, X., Ke, K., Yang, W., Lin, J., & Huang, N. (2025). Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein and/or Inferior Vena Cava Tumor Thrombus. CardioVascular and Interventional Radiology, 48(3), 314-326. https://doi.org/10.1007/s00270-024-03919-2

Chicago Style (17th ed.) Citation

Lin, Long-Wang, Yu-Xia Nian, Xin Lin, Kun Ke, Wei-Zhu Yang, Jun-Qing Lin, and Ning Huang. "Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein And/or Inferior Vena Cava Tumor Thrombus." CardioVascular and Interventional Radiology 48, no. 3 (2025): 314-326. https://doi.org/10.1007/s00270-024-03919-2.

MLA (9th ed.) Citation

Lin, Long-Wang, et al. "Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein And/or Inferior Vena Cava Tumor Thrombus." CardioVascular and Interventional Radiology, vol. 48, no. 3, 2025, pp. 314-326, https://doi.org/10.1007/s00270-024-03919-2.